95 related articles for article (PubMed ID: 23422370)
21. Resting brain connectivity: changes during the progress of Alzheimer disease.
Zhang HY; Wang SJ; Liu B; Ma ZL; Yang M; Zhang ZJ; Teng GJ
Radiology; 2010 Aug; 256(2):598-606. PubMed ID: 20656843
[TBL] [Abstract][Full Text] [Related]
22. 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy.
Winblad B; Wimo A; Engedal K; Soininen H; Verhey F; Waldemar G; Wetterholm AL; Haglund A; Zhang R; Schindler R
Dement Geriatr Cogn Disord; 2006; 21(5-6):353-63. PubMed ID: 16508298
[TBL] [Abstract][Full Text] [Related]
23. The neural correlates of verbal short-term memory in Alzheimer's disease: an fMRI study.
Peters F; Collette F; Degueldre C; Sterpenich V; Majerus S; Salmon E
Brain; 2009 Jul; 132(Pt 7):1833-46. PubMed ID: 19433442
[TBL] [Abstract][Full Text] [Related]
24. Synergistic effects of antidementia drugs on spatial learning and recall in the APP23 transgenic mouse model of Alzheimer's disease.
Neumeister KL; Riepe MW
J Alzheimers Dis; 2012; 30(2):245-51. PubMed ID: 22414570
[TBL] [Abstract][Full Text] [Related]
25. Detecting effects of donepezil on visual selective attention using signal detection parameters in Alzheimer's disease.
Foldi NS; White RE; Schaefer LA
Int J Geriatr Psychiatry; 2005 May; 20(5):485-8. PubMed ID: 15852461
[TBL] [Abstract][Full Text] [Related]
26. High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.
Bartha R; Smith M; Rupsingh R; Rylett J; Wells JL; Borrie MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):786-93. PubMed ID: 18252268
[TBL] [Abstract][Full Text] [Related]
27. The effect of APOE ε4 allele on cholinesterase inhibitors in patients with Alzheimer disease: evaluation of the feasibility of resting state functional connectivity magnetic resonance imaging.
Wang L; Day J; Roe CM; Brier MR; Thomas JB; Benzinger TL; Morris JC; Ances BM
Alzheimer Dis Assoc Disord; 2014; 28(2):122-7. PubMed ID: 24830360
[TBL] [Abstract][Full Text] [Related]
28. Functional neuroanatomy of sustained memory encoding performance in healthy aging and in Alzheimer's disease.
Weis S; Leube D; Erb M; Heun R; Grodd W; Kircher T
Int J Neurosci; 2011 Jul; 121(7):384-92. PubMed ID: 21446782
[TBL] [Abstract][Full Text] [Related]
29. The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients.
Reale M; Iarlori C; Gambi F; Feliciani C; Isabella L; Gambi D
Neuropharmacology; 2006 Apr; 50(5):606-13. PubMed ID: 16445950
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
[TBL] [Abstract][Full Text] [Related]
31. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
Lu S; Hill J; Fillit H
Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
[TBL] [Abstract][Full Text] [Related]
32. Cognitive reserve modulates task-induced activations and deactivations in healthy elders, amnestic mild cognitive impairment and mild Alzheimer's disease.
Bosch B; Bartrés-Faz D; Rami L; Arenaza-Urquijo EM; Fernández-Espejo D; Junqué C; Solé-Padullés C; Sánchez-Valle R; Bargalló N; Falcón C; Molinuevo JL
Cortex; 2010 Apr; 46(4):451-61. PubMed ID: 19560134
[TBL] [Abstract][Full Text] [Related]
33. Treatment effects of therapeutic cholinesterase inhibitors on visuospatial processing in Alzheimer's disease: a longitudinal functional MRI study.
Thiyagesh SN; Farrow TF; Parks RW; Accosta-Mesa H; Hunter MD; Young C; Wilkinson ID; Woodruff PW
Dement Geriatr Cogn Disord; 2010; 29(2):176-88. PubMed ID: 20215749
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
[TBL] [Abstract][Full Text] [Related]
35. Recovery of hippocampal network connectivity correlates with cognitive improvement in mild Alzheimer's disease patients treated with donepezil assessed by resting-state fMRI.
Goveas JS; Xie C; Ward BD; Wu Z; Li W; Franczak M; Jones JL; Antuono PG; Li SJ
J Magn Reson Imaging; 2011 Oct; 34(4):764-73. PubMed ID: 21769962
[TBL] [Abstract][Full Text] [Related]
36. Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy.
Rodriguez G; Vitali P; De Leo C; De Carli F; Girtler N; Nobili F
Neuropsychobiology; 2002; 46(1):49-56. PubMed ID: 12207147
[TBL] [Abstract][Full Text] [Related]
37. Effects of donepezil on the amplitude of low-frequency fluctuations in the brain of patients with Alzheimer's disease: evidence from resting-state functional magnetic resonance imaging.
Yang H; Zhang J; Cheng J
Neuroreport; 2021 Aug; 32(11):907-912. PubMed ID: 34029287
[TBL] [Abstract][Full Text] [Related]
38. Frontoparietal cognitive control of verbal memory recall in Alzheimer's disease.
Dhanjal NS; Wise RJ
Ann Neurol; 2014 Aug; 76(2):241-51. PubMed ID: 24933580
[TBL] [Abstract][Full Text] [Related]
39. Established donepezil treatment modulates task relevant regional brain activation in early Alzheimer's disease.
McGeown WJ; Shanks MF; Forbes-McKay KE; Waiter GD; Elrick I; Venneri MG; Venneri A
Curr Alzheimer Res; 2010 Aug; 7(5):415-27. PubMed ID: 20455867
[TBL] [Abstract][Full Text] [Related]
40. Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer's disease.
McLaren DG; Sreenivasan A; Diamond EL; Mitchell MB; Van Dijk KR; Deluca AN; O'Brien JL; Rentz DM; Sperling RA; Atri A
Neurodegener Dis; 2012; 9(4):176-86. PubMed ID: 22456451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
